Study: Aspirin linked to increased longevity after prostate cancer

CINCINNATI - A new study suggests aspirin may lower the risk of dying from prostate cancer.

Researchers found patients who took aspirin after receiving radiotherapy or a prostatectomy had a higher survival rate. The correlation was most prominent in patients with high-risk disease.

The study followed about 2,200 men for more than 10 years. Prostate cancer is the most common non-skin cancer among males, and the second-leading cancer killer.

The study is published in this month Journal of Clinical Oncology.

To read the full study, go to www.sciencedaily.com/releases/2012/08/120828170725.htm .